WallStreetZenWallStreetZen

NASDAQ: OM
Outset Medical Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for OM

Based on 1 analyst offering 12 month price targets for Outset Medical Inc

Min Forecast
$45.00+308.72%
Avg Forecast
$45.00+308.72%
Max Forecast
$45.00+308.72%

Should I buy or sell OM stock?

Based on 1 analyst offering ratings for Outset Medical Inc.

Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
1 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Our proven Zen Rating quant model agrees with analyst consensus with a "Hold" rating. Learn More

Be the first to know when Wall Street analysts revise their OM stock forecasts and price targets.

OM stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-01-07

1 of 1

Forecast return on equity

Is OM forecast to generate an efficient return?

Company
N/A
Industry
23.09%
Market
61.97%

Forecast return on assets

Is OM forecast to generate an efficient return on assets?

Company
N/A
Industry
12.29%

OM earnings per share forecast

What is OM's earnings per share in the next 2 years based on estimates from 2 analysts?

Avg 1 year Forecast
-$5.32
Avg 2 year Forecast
-$4.88

OM revenue forecast

What is OM's revenue in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
$120.1M+5.63%
Avg 2 year Forecast
$133.6M+17.47%
Avg 3 year Forecast
$147.1M+29.39%
OM's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

OM revenue growth forecast

How is OM forecast to perform vs Medical Devices companies and vs the US market?

Company
8.39%
Industry
8.12%
Market
10.7%
OM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
OM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

OM vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
OM$11.01$45.00+308.72%Hold
PTHL$2.80N/AN/A
TELA$0.96$5.33+457.85%Buy
APYX$0.98N/AN/A
NVNO$2.45N/AN/A
View Top Medical Device Stocks

Outset Medical Stock Forecast FAQ

Is Outset Medical Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: OM) stock is to Hold OM stock.

Out of 1 analyst, 0 (0%) are recommending OM as a Strong Buy, 0 (0%) are recommending OM as a Buy, 1 (100%) are recommending OM as a Hold, 0 (0%) are recommending OM as a Sell, and 0 (0%) are recommending OM as a Strong Sell.

If you're new to stock investing, here's how to buy Outset Medical stock.

What is OM's earnings growth forecast for 2025-2026?

(NASDAQ: OM) Outset Medical's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 24.37%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 23.64%.

Outset Medical's earnings in 2025 is -$127,976,000.On average, 2 Wall Street analysts forecast OM's earnings for 2025 to be -$19,115,457, with the lowest OM earnings forecast at -$19,259,182, and the highest OM earnings forecast at -$18,971,732.

In 2026, OM is forecast to generate -$17,516,514 in earnings, with the lowest earnings forecast at -$18,971,732 and the highest earnings forecast at -$16,061,296.

What is OM's revenue growth forecast for 2025-2027?

(NASDAQ: OM) Outset Medical's forecast annual revenue growth rate of 8.39% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.12%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.7%.

Outset Medical's revenue in 2025 is $113,689,000.On average, 2 Wall Street analysts forecast OM's revenue for 2025 to be $431,499,102, with the lowest OM revenue forecast at $431,175,720, and the highest OM revenue forecast at $431,822,484. On average, 2 Wall Street analysts forecast OM's revenue for 2026 to be $479,862,645, with the lowest OM revenue forecast at $476,089,858, and the highest OM revenue forecast at $483,635,433.

In 2027, OM is forecast to generate $528,549,570 in revenue, with the lowest revenue forecast at $528,549,570 and the highest revenue forecast at $528,549,570.

What is OM's forecast return on assets (ROA) for 2025-2027?

(NASDAQ: OM) forecast ROA is N/A, which is lower than the forecast US Medical Devices industry average of 12.29%.

What is OM's Price Target?

According to 1 Wall Street analyst that have issued a 1 year OM price target, the average OM price target is $45.00, with the highest OM stock price forecast at $45.00 and the lowest OM stock price forecast at $45.00.

The Wall Street analyst predicted that Outset Medical's share price could reach $45.00 by Jan 7, 2026. The average Outset Medical stock price prediction forecasts a potential upside of 308.72% from the current OM share price of $11.01.

What is OM's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: OM) Outset Medical's current Earnings Per Share (EPS) is -$36.90. On average, analysts forecast that OM's EPS will be -$5.32 for 2025, with the lowest EPS forecast at -$5.36, and the highest EPS forecast at -$5.28. In 2026, OM's EPS is forecast to hit -$4.88 (min: -$5.28, max: -$4.47).

What is OM's forecast return on equity (ROE) for 2025-2027?

(NASDAQ: OM) forecast ROE is N/A, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.